HSBC Holdings (LSE:HSBA) Calls 2027 Notes, Is The Stock Overvalued?

HSBC Holdings (LSE:HSBA) has informed holders of its CHF 300,000,000 0.3200% Notes due 2027 that it will exercise its issuer call option and redeem the bonds in November 2026.

HSBC Holdings shares trade at £15.492 after a small 1-day share price decline of 1.63%. However, the 90-day share price return of 17.20% and year-to-date gain of 29.99% indicate momentum that aligns with a 1-year total shareholder return of 62.42% and a 5-year total shareholder return of 461.87%.

Scan how HSBC Holdings compares with other large banks by reviewing a hand-picked set of list of solid balance sheet and fundamentals (10 results) in similar financial groups.

HSBC Holdings has delivered strong rewards to shareholders and is now calling a portion of its low coupon debt, a move that signals confidence in its balance sheet. The key question is whether the current share price already reflects that strength.

Most Popular Narrative: 5% Overvalued

HSBC Holdings last closed at £15.49, while the most followed narrative pegs fair value nearer £14.71, so the current valuation leans slightly above that framework.

The strategic shift away from underperforming and non-core businesses in Europe and the Americas, and redeployment of capital into high-return businesses in Asia and the Middle East, is expected to improve overall net interest margins and boost group return on equity through better allocation of resources.

Read the complete narrative. Read the complete narrative.

Readers may want to examine the revenue trajectory and margin profile that narrative is assuming, as it leans heavily on compounding earnings and a richer mix of fee income.

Result: Fair Value of £14.71 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

Still, the narrative can crack if Hong Kong commercial real estate drives higher credit losses or if heavy AI and digital spending erodes margins.

Find out about the key risks to this HSBC Holdings narrative.

Another View: HSBC Holdings Through The DCF Lens

Analyst narratives lean on a fair value near £14.71, yet the SWS DCF model points in a very different direction. On that framework, HSBC Holdings at £15.49 trades about 33% below an estimated future cash flow value of £23.07. This frames the same cash flows as a potential value gap rather than a slight premium. Which perspective do you think better reflects how this bank will actually generate cash over time?

For readers who want to see how that cash flow view is built line by line, it is worth taking a closer look at the SWS DCF model in full. Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out HSBC Holdings for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 10 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Mixed signals around HSBC Holdings can feel confusing. Move quickly to review the full data, weigh both the concerns and the potential upsides, then dig into the 3 key rewards and 3 important warning signs.

Looking for more investment ideas beyond HSBC Holdings?

Use the momentum from understanding HSBC Holdings to widen your opportunity set with a focused sweep through other potential candidates on the Simply Wall St Screener.

• Target resilient balance sheets and steady cash generation by reviewing a curated list of solid balance sheet and fundamentals (10 results) that can complement or contrast with HSBC Holdings in your portfolio.
• Hunt for potential value gaps by scanning a 10 high quality undervalued stocks that filters for quality businesses that trade at prices that might not fully reflect their fundamentals.
• Strengthen your income stream by checking a 1 dividend fortresses built around higher-yield payers that still clear key financial health checks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com